Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Holly Posner"'
Autor:
Lloyd Knapp, Verne Pitman, Nandan Yardi, Paul Glue, Daniel Friedman, Holly Posner, Mary Almas, Jacqueline A. French
Publikováno v:
Neurology
Objective: To evaluate the comparative safety and adjunctive efficacy of pregabalin and gabapentin in reducing seizure frequency in patients with partial-onset seizures based on prestudy modeling showing superior efficacy for pregabalin. Methods: The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276e3a09719f99d2065c7da4f86c4abc
https://doi.org/10.1212/wnl.0000000000003118
https://doi.org/10.1212/wnl.0000000000003118
Autor:
Holly, Posner, Rosie, Curiel, Chris, Edgar, Suzanne, Hendrix, Enchi, Liu, David A, Loewenstein, Glenn, Morrison, Leslie, Shinobu, Keith, Wesnes, Philip D, Harvey
Publikováno v:
Innovations in clinical neuroscience. 14(1-2)
An evolving paradigm shift in the diagnostic conceptualization of Alzheimer's disease is reflected in its recently updated diagnostic criteria from the National Institute on Aging-Alzheimer's Association and the International Working Group. Additiona
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f891dcedcb6f5275e7daa4e4aa72235e
https://pubmed.ncbi.nlm.nih.gov/28386518
https://pubmed.ncbi.nlm.nih.gov/28386518
Autor:
Philip D, Harvey, Stephanie, Cosentino, Rosie, Curiel, Terry E, Goldberg, Jeffrey, Kaye, David, Loewenstein, Daniel, Marson, David, Salmon, Keith, Wesnes, Holly, Posner
Publikováno v:
Innovations in clinical neuroscience. 14(1-2)
Assessment of the earlier stages of Alzheimer’s disease requires different strategies than those previously developed for fully syndromal Alzheimer’s disease . This challenge is further magnified in very early stages, where symptomatology may be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bfcf10fb21ecd0d8838d6f2da4af922f
https://pubmed.ncbi.nlm.nih.gov/28386519
https://pubmed.ncbi.nlm.nih.gov/28386519
Autor:
Lloyd Knapp, Marci L. Chew, Jacqueline A. French, Verne Pitman, Holly Posner, Victor Biton, Daniel Friedman, Christian Brandt, Sarah Dubrava
Publikováno v:
Epilepsia. 55:1220-1228
Summary Objectives To assess the efficacy and tolerability of add-on pregabalin controlled-release formulation (PGB-CR) (doses of 165 or 330 mg/day) in patients with partial-onset seizures (POS). Methods This was a randomized, double-blind (DB), para
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b092fdb87e68c77024053d68972b044
https://doi.org/10.1111/epi.12690
https://doi.org/10.1111/epi.12690
Publikováno v:
Epilepsia. 55:1048-1057
Summary Objectives To assess the comparative efficacy and safety of pregabalin and levetiracetam for the reduction of seizure frequency in patients with partial seizures. Methods This was a randomized, double-blind, flexible-dose, parallel-group noni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09dd88e6bca4d4dd19a5de83c301792b
https://doi.org/10.1111/epi.12679
https://doi.org/10.1111/epi.12679
Autor:
Richard C. Green, Mark W. Logue, Charles DeCarli, Holly Posner, Heng Zou, Stephen W. Hurt, L. Adrienne Cupples, Lindsay A. Farrer, Margaret Moline, K. L. Lunetta
Publikováno v:
Alzheimer's & Dementia. 7:493-500
Background Recent pathological studies report vascular pathology in clinically diagnosed Alzheimer's disease (AD) and AD pathology in clinically diagnosed vascular dementia (VaD). We compared magnetic resonance imaging (MRI) measures of vascular brai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f6f571a4e3dd19c9945f78ea179fc67
https://doi.org/10.1016/j.jalz.2011.01.004
https://doi.org/10.1016/j.jalz.2011.01.004
Autor:
Rachel Schindler, Sandra E. Black, Gustavo C. Román, Margaret Moline, Charles DeCarli, Donald R. Royall, Stephen Salloway, Michael Weiner, Holly Posner, Dinesh Kumar
Publikováno v:
Stroke. 41:1213-1221
Background and Purpose— We sought to assess the efficacy and safety of donepezil in patients with vascular dementia (VaD) fulfilling National Institute of Neurological Disorders and Stroke–Association Internationale pour la Recherche et l’Ensei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e44ba90ff973abb969d5eab90db9c7
https://doi.org/10.1161/strokeaha.109.570077
https://doi.org/10.1161/strokeaha.109.570077
Autor:
Karyn Boundy, David Wilkinson, Holly Posner, Dinesh Kumar, Rachel Schindler, Gustavo C. Roman, Stephen Salloway, Jane Hecker
Publikováno v:
International Journal of Geriatric Psychiatry. 25:305-313
Objective To determine the long-term tolerability and efficacy of donepezil in patients with vascular dementia (VaD). Methods International, multicentre, open-label, 30-week extension study of two 24-week, randomised, double-blind, placebo-controlled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227bec35bd10496f3df7745eca856fac
https://doi.org/10.1002/gps.2340
https://doi.org/10.1002/gps.2340
Autor:
Rafael Lantigua, Richard Mayeux, José A. Luchsinger, Yaakov Stern, Ming-Xin Tang, Holly Posner
Publikováno v:
Scopus-Elsevier
Background: Hypertension at the age of 45 to 50 years may predispose to AD later in life. It is not known whether hypertension after age 65 years also contributes to AD risk, and its effect on cognitive function is also not fully understood.Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31f6994c36550316c1508f0a4ca3d6b0
https://doi.org/10.1212/wnl.58.8.1175
https://doi.org/10.1212/wnl.58.8.1175
Autor:
Enchi Liu, Adam J. Schwarz, Michael T. Ropacki, Holly Posner, Per Johan Luthman, Annette Merdes
Publikováno v:
Alzheimer's & Dementia. 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caa9b39ffa1a09e2181dfc8eeb656fb5
https://doi.org/10.1016/j.jalz.2014.04.373
https://doi.org/10.1016/j.jalz.2014.04.373